Archives

Andor Health Poised to be the Only Multimodal AI Infrastructure to drive Patient Conversation across the Care Continuum

B ORLANDO, Fla., April 9, 2026 /PRNewswire/ —  Andor Health, the leader in multimodal agentic AI software infrastructure for healthcare, today announced a major expansion… Login to continue reading Login…

Read MoreAndor Health Poised to be the Only Multimodal AI Infrastructure to drive Patient Conversation across the Care Continuum

New Peer-Reviewed Scientific Publication Establishes Rationale for Combination Pharmacotherapy in Achieving Durable Weight Management

B Review highlights multi-pathway, mechanistically informed approaches to obesity treatment BRENTWOOD, Tenn., April 9, 2026 /PRNewswire/ — Currax Pharmaceuticals LLC (“Currax”) spotlights the publication of a… Login to continue reading Login…

Read MoreNew Peer-Reviewed Scientific Publication Establishes Rationale for Combination Pharmacotherapy in Achieving Durable Weight Management

Norm Law Appoints Market-Leading Transactions Partner Bill Mone as Head of Private Equity, Strengthening Private Equity and M&A Capabilities

B NEW YORK, April 9, 2026 /PRNewswire/ — Norm Law, LLP (“Norm Law”), an AI-native law firm built for global institutional clients, today announced the appointment… Login to continue reading Login…

Read MoreNorm Law Appoints Market-Leading Transactions Partner Bill Mone as Head of Private Equity, Strengthening Private Equity and M&A Capabilities

MEALS ON WHEELS AMERICA ANNOUNCES $70 MILLION GIFT FROM PHILANTHROPIST MACKENZIE SCOTT THAT WILL HELP STRENGTHEN THE MEALS ON WHEELS NETWORK

B Philanthropist MacKenzie Scott recently donated $70 million to Meals on Wheels America, reflecting a powerful level of trust in the organization’s mission, leadership and… Login to continue reading Login…

Read MoreMEALS ON WHEELS AMERICA ANNOUNCES $70 MILLION GIFT FROM PHILANTHROPIST MACKENZIE SCOTT THAT WILL HELP STRENGTHEN THE MEALS ON WHEELS NETWORK

Gan & Lee Pharmaceuticals Signs Exclusive License Agreement with JW Pharmaceutical, the Leading South Korean Pharma, to Advance the Global Commercialization of the Innovative GLP-1 Receptor Agonist Bofanglutide

B BEIJING and BRIDGEWATER, N.J., April 9, 2026 /PRNewswire/ — Gan & Lee Pharmaceuticals (hereinafter referred to as “Gan & Lee”, SSE: 603087) announced the… Login to continue reading Login…

Read MoreGan & Lee Pharmaceuticals Signs Exclusive License Agreement with JW Pharmaceutical, the Leading South Korean Pharma, to Advance the Global Commercialization of the Innovative GLP-1 Receptor Agonist Bofanglutide